Laboratory Biosafety Issues Related to Coronavirus Disease 2019
Abstract Indroduction The outbreak of Novel Coronavirus Pneumonia SARS-CoV-2 has necessitated the reinforcement of infection control measures in the hospital and laboratory setting. Contact and droplet infection control measures are advised for handling patients diagnosed with COVID-19 and airborne...
Gespeichert in:
| Veröffentlicht in: | Indian journal of medical and paediatric oncology 2020-07, Vol.41 (4), p.450-453 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 453 |
|---|---|
| container_issue | 4 |
| container_start_page | 450 |
| container_title | Indian journal of medical and paediatric oncology |
| container_volume | 41 |
| creator | Bhat, Vivek Chavan, Preeti Biswas, Sanjay Gupta, Sudeep Khattry, Navin Thakkar, Prafulla |
| description | Abstract
Indroduction
The outbreak of Novel Coronavirus Pneumonia SARS-CoV-2 has necessitated the reinforcement of infection control measures in the hospital and laboratory setting. Contact and droplet infection control measures are advised for handling patients diagnosed with COVID-19 and airborne precautions for procedures that generate aerosols.
Pre-ananalytical Phase
Risk assessment is conducted for all steps of laboratory processes viz. preanalytical, analytical and postanalytical. Standard Precautions must be followed at all times when laboratory staff handle clinical specimens that may contain infectious microorganism. Standard precautions must include hand hygiene along with the use of personal protective equipment (PPE). All samples are collected in appropriate containers and all containers are decontaminated by 62-71% ethanol (alcohol) before transporting them to the laboratory in triple packaging.
Analytical Phase
All samples should undergo initial processing in a biosafety cabinet (BSC). It should be ensured while undertaking all technical procedures that there is minimal formation of aerosols and droplets.
Post-analytical Phase
All biomedical waste should be disposed as per state and national guidelines. Decontamination includes use of 1% sodium hypochlorite, 62-71% ethanol for surface disinfection or Hydrogen peroxide (0.5%).
Conclusion
These laboratory biosafety measures are important to minimise the risk of laboratory transmission of COVID-19 to health care workers. |
| doi_str_mv | 10.4103/ijmpo.ijmpo_176_20 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2532561908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A634381862</galeid><sourcerecordid>A634381862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c520o-587c00ddaee7d7f1627d88d8cd8941c1990e65a6202ae2a6f30b66abf74b40723</originalsourceid><addsrcrecordid>eNp9kVFr2zAUhc1YYV27P7Anw2BvSa9kS5afRpt2bSFQGNuzUKzrRantm0pyQ_793HglKZQgkC7ifOcInST5ymCaM8gu3Kpd03S3a1ZIzeFDcgplISac8fLjbmYToQT7lHwOYQWQCSbVafJjbhbkTSS_Ta8cBVNj3Kb3IfQY0l_YmIg2jZTOyFNnnp3vQ3rtApqAKQdWnicntWkCfvl_niV_ft78nt1N5g-397PL-aQSHGhILioAaw1iYYuaSV5YpayqrCpzVrGyBJTCSA7cIDeyzmAhpVnURb7IoeDZWfJt9F17ehreFvWKet8NkZqLjAvJSlB71V_ToHZdTdGbqnWh0pcyyzPFlHzxmr6jGpbF1lXUYe2G-zfA9wNgiaaJy0BNHx114a2Qj8LKUwgea732rjV-qxnol6L0WNFhUQN0PUIbaiL68Nj0G_S6RfvY0eYIqXMB-rW_wYaNNnHpsMX9_xyJ_gcwdK-O</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532561908</pqid></control><display><type>article</type><title>Laboratory Biosafety Issues Related to Coronavirus Disease 2019</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Thieme Connect Journals Open Access</source><creator>Bhat, Vivek ; Chavan, Preeti ; Biswas, Sanjay ; Gupta, Sudeep ; Khattry, Navin ; Thakkar, Prafulla</creator><creatorcontrib>Bhat, Vivek ; Chavan, Preeti ; Biswas, Sanjay ; Gupta, Sudeep ; Khattry, Navin ; Thakkar, Prafulla</creatorcontrib><description>Abstract
Indroduction
The outbreak of Novel Coronavirus Pneumonia SARS-CoV-2 has necessitated the reinforcement of infection control measures in the hospital and laboratory setting. Contact and droplet infection control measures are advised for handling patients diagnosed with COVID-19 and airborne precautions for procedures that generate aerosols.
Pre-ananalytical Phase
Risk assessment is conducted for all steps of laboratory processes viz. preanalytical, analytical and postanalytical. Standard Precautions must be followed at all times when laboratory staff handle clinical specimens that may contain infectious microorganism. Standard precautions must include hand hygiene along with the use of personal protective equipment (PPE). All samples are collected in appropriate containers and all containers are decontaminated by 62-71% ethanol (alcohol) before transporting them to the laboratory in triple packaging.
Analytical Phase
All samples should undergo initial processing in a biosafety cabinet (BSC). It should be ensured while undertaking all technical procedures that there is minimal formation of aerosols and droplets.
Post-analytical Phase
All biomedical waste should be disposed as per state and national guidelines. Decontamination includes use of 1% sodium hypochlorite, 62-71% ethanol for surface disinfection or Hydrogen peroxide (0.5%).
Conclusion
These laboratory biosafety measures are important to minimise the risk of laboratory transmission of COVID-19 to health care workers.</description><identifier>ISSN: 0971-5851</identifier><identifier>EISSN: 0975-2129</identifier><identifier>DOI: 10.4103/ijmpo.ijmpo_176_20</identifier><language>eng</language><publisher>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>Aerosols ; Biosafety ; Coronaviruses ; COVID-19 ; Disease control ; Disease transmission ; Health aspects ; Hygiene ; Infection ; Infection control ; Laboratories ; Original Article ; Risk assessment ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Indian journal of medical and paediatric oncology, 2020-07, Vol.41 (4), p.450-453</ispartof><rights>Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)</rights><rights>COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.</rights><rights>2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c520o-587c00ddaee7d7f1627d88d8cd8941c1990e65a6202ae2a6f30b66abf74b40723</citedby><cites>FETCH-LOGICAL-c520o-587c00ddaee7d7f1627d88d8cd8941c1990e65a6202ae2a6f30b66abf74b40723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.4103/ijmpo.ijmpo_176_20.pdf$$EPDF$$P50$$Gthieme$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.4103/ijmpo.ijmpo_176_20$$EHTML$$P50$$Gthieme$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,20870,27901,27902,54562,54590</link.rule.ids></links><search><creatorcontrib>Bhat, Vivek</creatorcontrib><creatorcontrib>Chavan, Preeti</creatorcontrib><creatorcontrib>Biswas, Sanjay</creatorcontrib><creatorcontrib>Gupta, Sudeep</creatorcontrib><creatorcontrib>Khattry, Navin</creatorcontrib><creatorcontrib>Thakkar, Prafulla</creatorcontrib><title>Laboratory Biosafety Issues Related to Coronavirus Disease 2019</title><title>Indian journal of medical and paediatric oncology</title><addtitle>Indian J Med Paediatr Oncol</addtitle><description>Abstract
Indroduction
The outbreak of Novel Coronavirus Pneumonia SARS-CoV-2 has necessitated the reinforcement of infection control measures in the hospital and laboratory setting. Contact and droplet infection control measures are advised for handling patients diagnosed with COVID-19 and airborne precautions for procedures that generate aerosols.
Pre-ananalytical Phase
Risk assessment is conducted for all steps of laboratory processes viz. preanalytical, analytical and postanalytical. Standard Precautions must be followed at all times when laboratory staff handle clinical specimens that may contain infectious microorganism. Standard precautions must include hand hygiene along with the use of personal protective equipment (PPE). All samples are collected in appropriate containers and all containers are decontaminated by 62-71% ethanol (alcohol) before transporting them to the laboratory in triple packaging.
Analytical Phase
All samples should undergo initial processing in a biosafety cabinet (BSC). It should be ensured while undertaking all technical procedures that there is minimal formation of aerosols and droplets.
Post-analytical Phase
All biomedical waste should be disposed as per state and national guidelines. Decontamination includes use of 1% sodium hypochlorite, 62-71% ethanol for surface disinfection or Hydrogen peroxide (0.5%).
Conclusion
These laboratory biosafety measures are important to minimise the risk of laboratory transmission of COVID-19 to health care workers.</description><subject>Aerosols</subject><subject>Biosafety</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease control</subject><subject>Disease transmission</subject><subject>Health aspects</subject><subject>Hygiene</subject><subject>Infection</subject><subject>Infection control</subject><subject>Laboratories</subject><subject>Original Article</subject><subject>Risk assessment</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0971-5851</issn><issn>0975-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kVFr2zAUhc1YYV27P7Anw2BvSa9kS5afRpt2bSFQGNuzUKzrRantm0pyQ_793HglKZQgkC7ifOcInST5ymCaM8gu3Kpd03S3a1ZIzeFDcgplISac8fLjbmYToQT7lHwOYQWQCSbVafJjbhbkTSS_Ta8cBVNj3Kb3IfQY0l_YmIg2jZTOyFNnnp3vQ3rtApqAKQdWnicntWkCfvl_niV_ft78nt1N5g-397PL-aQSHGhILioAaw1iYYuaSV5YpayqrCpzVrGyBJTCSA7cIDeyzmAhpVnURb7IoeDZWfJt9F17ehreFvWKet8NkZqLjAvJSlB71V_ToHZdTdGbqnWh0pcyyzPFlHzxmr6jGpbF1lXUYe2G-zfA9wNgiaaJy0BNHx114a2Qj8LKUwgea732rjV-qxnol6L0WNFhUQN0PUIbaiL68Nj0G_S6RfvY0eYIqXMB-rW_wYaNNnHpsMX9_xyJ_gcwdK-O</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Bhat, Vivek</creator><creator>Chavan, Preeti</creator><creator>Biswas, Sanjay</creator><creator>Gupta, Sudeep</creator><creator>Khattry, Navin</creator><creator>Thakkar, Prafulla</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>0U6</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>202007</creationdate><title>Laboratory Biosafety Issues Related to Coronavirus Disease 2019</title><author>Bhat, Vivek ; Chavan, Preeti ; Biswas, Sanjay ; Gupta, Sudeep ; Khattry, Navin ; Thakkar, Prafulla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c520o-587c00ddaee7d7f1627d88d8cd8941c1990e65a6202ae2a6f30b66abf74b40723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aerosols</topic><topic>Biosafety</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease control</topic><topic>Disease transmission</topic><topic>Health aspects</topic><topic>Hygiene</topic><topic>Infection</topic><topic>Infection control</topic><topic>Laboratories</topic><topic>Original Article</topic><topic>Risk assessment</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhat, Vivek</creatorcontrib><creatorcontrib>Chavan, Preeti</creatorcontrib><creatorcontrib>Biswas, Sanjay</creatorcontrib><creatorcontrib>Gupta, Sudeep</creatorcontrib><creatorcontrib>Khattry, Navin</creatorcontrib><creatorcontrib>Thakkar, Prafulla</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Indian journal of medical and paediatric oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhat, Vivek</au><au>Chavan, Preeti</au><au>Biswas, Sanjay</au><au>Gupta, Sudeep</au><au>Khattry, Navin</au><au>Thakkar, Prafulla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laboratory Biosafety Issues Related to Coronavirus Disease 2019</atitle><jtitle>Indian journal of medical and paediatric oncology</jtitle><addtitle>Indian J Med Paediatr Oncol</addtitle><date>2020-07</date><risdate>2020</risdate><volume>41</volume><issue>4</issue><spage>450</spage><epage>453</epage><pages>450-453</pages><issn>0971-5851</issn><eissn>0975-2129</eissn><abstract>Abstract
Indroduction
The outbreak of Novel Coronavirus Pneumonia SARS-CoV-2 has necessitated the reinforcement of infection control measures in the hospital and laboratory setting. Contact and droplet infection control measures are advised for handling patients diagnosed with COVID-19 and airborne precautions for procedures that generate aerosols.
Pre-ananalytical Phase
Risk assessment is conducted for all steps of laboratory processes viz. preanalytical, analytical and postanalytical. Standard Precautions must be followed at all times when laboratory staff handle clinical specimens that may contain infectious microorganism. Standard precautions must include hand hygiene along with the use of personal protective equipment (PPE). All samples are collected in appropriate containers and all containers are decontaminated by 62-71% ethanol (alcohol) before transporting them to the laboratory in triple packaging.
Analytical Phase
All samples should undergo initial processing in a biosafety cabinet (BSC). It should be ensured while undertaking all technical procedures that there is minimal formation of aerosols and droplets.
Post-analytical Phase
All biomedical waste should be disposed as per state and national guidelines. Decontamination includes use of 1% sodium hypochlorite, 62-71% ethanol for surface disinfection or Hydrogen peroxide (0.5%).
Conclusion
These laboratory biosafety measures are important to minimise the risk of laboratory transmission of COVID-19 to health care workers.</abstract><cop>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India</cop><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><doi>10.4103/ijmpo.ijmpo_176_20</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0971-5851 |
| ispartof | Indian journal of medical and paediatric oncology, 2020-07, Vol.41 (4), p.450-453 |
| issn | 0971-5851 0975-2129 |
| language | eng |
| recordid | cdi_proquest_journals_2532561908 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Thieme Connect Journals Open Access |
| subjects | Aerosols Biosafety Coronaviruses COVID-19 Disease control Disease transmission Health aspects Hygiene Infection Infection control Laboratories Original Article Risk assessment Severe acute respiratory syndrome coronavirus 2 |
| title | Laboratory Biosafety Issues Related to Coronavirus Disease 2019 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T16%3A12%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laboratory%20Biosafety%20Issues%20Related%20to%20Coronavirus%20Disease%202019&rft.jtitle=Indian%20journal%20of%20medical%20and%20paediatric%20oncology&rft.au=Bhat,%20Vivek&rft.date=2020-07&rft.volume=41&rft.issue=4&rft.spage=450&rft.epage=453&rft.pages=450-453&rft.issn=0971-5851&rft.eissn=0975-2129&rft_id=info:doi/10.4103/ijmpo.ijmpo_176_20&rft_dat=%3Cgale_proqu%3EA634381862%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2532561908&rft_id=info:pmid/&rft_galeid=A634381862&rfr_iscdi=true |